NDAQ Nasdaq Inc.

Delisting of Securities of Core Scientific, Inc.; The Very Good Food Company Inc.; HyreCar Inc.; Reeds, Inc.; Sorrento Therapeutics, Inc.; CYREN Ltd.; Lucira Health, Inc.; Qutoutiao Inc.; and Sio Gene Therapies Inc. from The Nasdaq Stock Market

Delisting of Securities of Core Scientific, Inc.; The Very Good Food Company Inc.; HyreCar Inc.; Reeds, Inc.; Sorrento Therapeutics, Inc.; CYREN Ltd.; Lucira Health, Inc.; Qutoutiao Inc.; and Sio Gene Therapies Inc. from The Nasdaq Stock Market

NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrant of Core Scientific, Inc. Core Scientific, Inc. securities were suspended on January 3, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares of The Very Good Food Company Inc. The Very Good Food Company Inc. common shares were suspended on January 23, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of HyreCar Inc. HyreCar Inc.’s common stock was suspended on February 3, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Reeds, Inc. Reeds, Inc.’s common stock was suspended on February 16, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Sorrento Therapeutics, Inc. Sorrento Therapeutics, Inc.’s common stock was suspended on February 23, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of CYREN Ltd. CYREN Ltd. ordinary shares were suspended on March 3, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Lucira Health, Inc. Lucira Health, Inc. common stock was suspended on March 6, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the American Depositary Shares of Qutoutiao Inc. Qutoutiao Inc. shares were suspended on March 23, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Sio Gene Therapies Inc. Sio Gene Therapies Inc. common stock was suspended on March 23, 2023, and has not traded on Nasdaq since that time.

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at  Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: .

-NDAQO-



EN
10/04/2023

Underlying

NDAQNasdaq Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nasdaq Inc.

 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Texas Launches with Inaugural Dual Listings

Nasdaq Texas Launches with Inaugural Dual Listings Nasdaq Texas Celebrates Official Launch with the Nasdaq Stock Market Closing Bell at the Alamo with the First Cohort of Dual Listings Nasdaq, Inc. to Dual List on Nasdaq Texas Alongside Inaugural Group SAN ANTONIO, March 05, 2026 (GLOBE NEWSWIRE) -- Nasdaq Texas will mark another milestone by ringing the Nasdaq Closing Bell at The Alamo, San Antonio, Texas, commemorating the 190th anniversary of the Battle of the Alamo and the full operational launch of Nasdaq Texas following approval of its listing rules from the U.S. Securities and Ex...

1h / 52m 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Executives to Present at Upcoming Investor Conferences

Nasdaq Executives to Present at Upcoming Investor Conferences NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in March with webcasts available at Nasdaq’s Investor Relations website: . Who:Sarah Youngwood, Executive Vice President & Chief Financial Officer, NasdaqWhat:Morgan Stanley Technology, Media & Telecom ConferenceWhen:Monday, March 2nd, 11:30 AM ET  Who:Jeremy Skule, Executive Vice President, Chief Strategy Officer & Executive Chair, Financial Crime Management Technology, NasdaqWhat:Raymond James 47thAnnual Instituti...

February 26, 2026 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Sto...

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 13, 2026 NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 13, 2026, short interest in 3,595 Nasdaq Global MarketSM securities totaled 15,834,216,597 shares compared with 15,574,683,465 shares in 3,547 Global Market issues reported for the prior settlement date of January 30, 2026. The mid-January short interest represents 2.25 days compared with 2.58 days for the prior reporting period. Short interest in 1,654 securities on The Nasdaq Capital M...

February 25, 2026 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for It...

Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for Its Next Phase of Scalable Growth at 2026 Investor Day Nasdaq raises medium-term Solutions revenue outlook to 9-12% growthMaintains medium-term outlook for expense growth of 5-8%Company reinforces its position as trusted transformation partner in the AI eraCommits to actioning AI productivity program with an expense efficiency target of $100 million by 2027 NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today will host its Investor Day at 8:00 a.m. ET, where Adena Friedman, Nasdaq Chair and CEO, Sarah ...

February 25, 2026 1 EN
NDAQ NASDAQ INC.

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Nasdaq, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 18 February 2026 in which we reassessed the appropriateness of the ratings in the context of t...

02/24/26 February 24, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch